Open access
Open access
Powered by Google Translator Translator

Daily Archives: December 14, 2022

Guideline | ADA 2023 Standards of Medical Care in Diabetes.

14 Dec, 2022 | 15:59h | UTC

Guideline Homepage: ADA 2023 Standards of Medical Care in Diabetes – American Diabetes Association

Introduction: Standards of Medical Care in Diabetes—2023

Summary of Revisions: Standards of Medical Care in Diabetes—2023

  1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023
  2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
  3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
  5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
  6. Glycemic Targets: Standards of Care in Diabetes—2023
  7. Diabetes Technology: Standards of Care in Diabetes—2023
  8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
  10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
  11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
  12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
  13. Older Adults: Standards of Care in Diabetes—2023
  14. Children and Adolescents: Standards of Care in Diabetes—2023
  15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
  16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
  17. Diabetes Advocacy: Standards of Care in Diabetes—2023

 

Special Report | Global burden of cardiovascular diseases and risks collaboration.

14 Dec, 2022 | 15:57h | UTC

Homepage and Infographic: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology

News Release: New report tracks latest trends in global cardiovascular health – Institute for Health Metrics and Evaluation

Introduction: The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health – Journal of the American College of Cardiology

Full Report: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology

 

Commentary on Twitter

 

Research Opportunities in the treatment of mitral valve prolapse: JACC Expert Panel.

14 Dec, 2022 | 15:10h | UTC

Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel – Journal of the American College of Cardiology

 

Cohort Study | Association between the use of mobile devices for calming and executive functioning in children aged 3 to 5 years.

14 Dec, 2022 | 15:07h | UTC

Longitudinal Associations Between Use of Mobile Devices for Calming and Emotional Reactivity and Executive Functioning in Children Aged 3 to 5 Years – JAMA Pediatrics (free for a limited period)

News Release: Frequently using digital devices to soothe young children may backfire – University of Michigan 

Commentary: Giving your child a screen may hinder emotional regulation, study says. Here’s what to do instead – CNN

 

RCT | A calorie-unrestricted low-carbohydrate, high-fat diet resulted in short-term weight loss and better glycemic control.

14 Dec, 2022 | 15:08h | UTC

Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Low-Carbohydrate, High-Fat Diet Beneficial in T2DM in Short Term – HealthDay

Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease – Annals of Internal Medicine

 

Commentary on Twitter

 

M-A | Predicting neurological outcome in adult patients with cardiac arrest.

14 Dec, 2022 | 15:02h | UTC

Predicting neurological outcome in adult patients with cardiac arrest: systematic review and meta-analysis of prediction model performance – Critical Care

 

Cohort Study | Assessment of depression and adherence to guideline-directed medical therapies following PCI.

14 Dec, 2022 | 14:59h | UTC

Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention – JAMA Network Open

Commentaries: 

More Evidence of the Association of Depression With Adherence to Medical Therapies in Coronary Heart Disease – JAMA Network Open

Individuals with depression less likely to adhere to medications following percutaneous coronary intervention – News Medical / University of Pittsburg 

 

Phase 2 RCT | Immediate surgery vs. short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer.

14 Dec, 2022 | 15:01h | UTC

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial – The Lancet Gastroenterology & Hepatology

News Release: Chemotherapy before surgery can improve survival rates in pancreatic cancer patients – University of Liverpool

 

Commentary on Twitter

 

RCT | Medication optimization vs. cognitive behavioral therapy in patients with chronic low back pain.

14 Dec, 2022 | 14:58h | UTC

Effect of Medication Optimization vs Cognitive Behavioral Therapy Among US Veterans With Chronic Low Back Pain Receiving Long-term Opioid Therapy: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 

RCT | Small trial suggests butyrate may be effective in reducing pediatric obesity.

14 Dec, 2022 | 14:56h | UTC

Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 

SR | Use of acupuncture for adult health conditions, 2013 to 2021.

14 Dec, 2022 | 14:54h | UTC

Use of Acupuncture for Adult Health Conditions, 2013 to 2021: A Systematic Review – JAMA Network Open

 

SR | Fundoplication in laparoscopic Heller’s cardiomyotomy for achalasia.

14 Dec, 2022 | 14:53h | UTC

Fundoplication in laparoscopic Heller’s cardiomyotomy for achalasia – Cochrane Library

Summary: Addition of a stomach wrap (fundoplication) around the food pipe (oesophagus) in keyhole (laparoscopic) surgery to treat achalasia – Cochrane Library

 

SR | BNP and NT-proBNP for the diagnosis of hemodynamically significant patent ductus arteriosus in preterm neonates.

14 Dec, 2022 | 14:49h | UTC

Brain natriuretic peptide and N‐terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates – Cochrane Library

Summary: In preterm infants, how accurate are the blood tests BNP and NT-proBNP in identifying PDAs (patent ductus arteriosus) that require further treatment? – Cochrane Library

 

SR | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

14 Dec, 2022 | 14:51h | UTC

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins – Cochrane Library

 

Podcast | Prostate cancer: screening, advanced testing, and survivorship.

14 Dec, 2022 | 14:48h | UTC

#371 Prostate Cancer: Screening, Advanced Testing, and Survivorship – The Curbsiders

 

RCT | Optimal treatment duration of bevacizumab as front-line therapy for advanced ovarian cancer.

14 Dec, 2022 | 14:44h | UTC

Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Treatment With Bevacizumab for 30 Months Provides No Benefit Over 15 Months in Ovarian Cancer – Cancer Network

 

Commentary on Twitter

 

RCT | Durvalumab with or without Tremelimumab plus chemotherapy for metastatic non–small-cell lung cancer.

14 Dec, 2022 | 14:47h | UTC

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study – Journal of Clinical Oncology

Commentary: Adding Tremelimumab and Durvalumab to Chemo Improves PFS, OS in mNSCLC – Cancer Therapy Advisor

 

Commentary on Twitter

 

RCT | Rogaratinib vs. chemotherapy in patients with advancer urothelial carcinoma selected based on FGFR1/3 mRNA expression.

14 Dec, 2022 | 14:45h | UTC

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression – Journal of Clinical Oncology

Commentary: Rogaratinib Is Noninferior to Chemo in Pretreated FGFR1/3 mRNA+ Locally Advanced or Metastatic Urothelial Carcinoma – OncLive

 

Commentary on Twitter

 

Post-trial follow-up | Radiotherapy vs. surgery of the axilla after a positive sentinel node in breast cancer.

14 Dec, 2022 | 14:42h | UTC

Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: ART Preferred Over ALND in Sentinel Node-Positive Early Breast Cancer – Cancer Therapy Advisor

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.